End Stage Renal Disease (ESRD)
Also known as: End Stage Renal Disease Patients / End Stage Renal Disease / Endstage Renal Disease / ESRD (End-Stage Renal Disease) / End Stage Renal Diseases / End-Stage Renal Disease (ESRD) / End- Stage Renal Disease Patients / End-Stage Renal Disease / ESRD / Chronic kidney disease, stage 5 / Chronic kidney disease stage 5 (disorder) / Chronic kidney disease stage 5 / Chronic kidney disease, unspecified / Chronic kidney disease (CKD) / Chronic renal failure syndrome (disorder) / Renal failure chronic / Chronic renal failure / Kidney failure chronic / Kidney Failure, Chronic / End stage renal failure / End-stage renal disease (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB08907 | Canagliflozin | A sodium-glucose co-transporter 2 (SGLT2) inhibitor used to manage hyperglycemia in type 2 diabetes mellitus (DM). Also used to reduce the risk of major cardiovascular events in patients with established cardiovascular disease and type 2 DM. |
| DB06292 | Dapagliflozin | A sodium-glucose cotransporter 2 inhibitor used in the management of type 2 diabetes mellitus. |
| DB09038 | Empagliflozin | An SGLT2 inhibitor used to manage type 2 diabetes mellitus. |
| DB06792 | Lanthanum carbonate | A phosphate binder indicated for the reduction of serum phosphate in patients with end stage renal disease. |
| DB00583 | Levocarnitine | A quaternary ammonium compound used to treat carnitine deficiency or to stimulate gastric and pancreatic secretions in hyperlipoproteinemia. |
| DB00331 | Metformin | A biguanide antihyperglycemic used in conjunction with diet and exercise for glycemic control in type 2 diabetes mellitus. It is also used off-label for insulin resistance in polycystic ovary syndrome (PCOS). |